Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Clinical trial NCT03908593 · UNKNOWN

Trial details

NCT number: NCT03908593
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Gastrointestinal Ulcer (Peptic) or Erosion Anti-Platelet Therapy Coronary Artery Bypass

Start date: 2019-10-14
Primary completion: 2023-12-30
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.